How do great research centres evolve? Through vision, collaboration, and people. When Dr. Chen Liang took the helm of what was then the McGill AIDS Centre, he saw an opportunity to build on a powerful legacy and expand its mission. Today, the Mark Wainberg Centre for Viral Diseases (MCVD) brings together experts tackling HIV, influenza, hepatitis C, HPV, SARS-CoV-2, Nipah virus, and other viral threats. In this spotlight, Dr. Liang reflects on the Centre’s evolution, the leadership lessons he learned from Mark Wainberg, and the role MI4 has played as a trusted partner in building a stronger, more collaborative viral disease research community. Full article 👉 https://lnkd.in/e_3Drdfg #McGill #MI4 #ViralDiseases #ResearchImpact #GlobalHealth #Collaboration #PublicHealth
MI4
Research Services
Montreal, Quebec 424 followers
We leverage translational research to prevent, cure and eliminate major infectious & immune threats to human health.
About us
MI4: Leveraging the power of translational research for the prevention, cure and elimination of major infectious & immune threats to human health. McGill/MUHC.
- Website
-
http://www.mcgill.ca/mi4
External link for MI4
- Industry
- Research Services
- Company size
- 2-10 employees
- Headquarters
- Montreal, Quebec
- Type
- Educational
Locations
-
Primary
Get directions
Hugessen House
Montreal, Quebec, CA
Employees at MI4
Updates
-
We're proud to see our own Dr. Marcel Behr featured in the Lasker Foundation's article "Vaccines' Little Helpers." The piece explores the history and impact of vaccine adjuvants, including Freund's adjuvant, a major tool in immunology research. As Dr. Behr notes, it has been "an incredibly valuable tool to study the immune system." #Immunology #Vaccines #Research #McGill #MedicalResearch
Jules Freund was born #OTD in 1890 in Budapest. He won a Basic Medical Research Lasker Award in 1959 for developing “Freund’s adjuvant,” immunization procedures against diseases such as tuberculosis, rabies, and poliomyelitis, while at the The National Institutes of Health. 🏆 Learn about the award: https://ow.ly/3IgI50Z6PJJ Adjuvants are immune system boosters, and Freund’s—which is a mixture of mineral oil and water spiked with dead tuberculosis (TB) bacteria—is one of the most potent ever developed. The mixture “has been an incredibly valuable tool to study the immune system,” says microbiologist Marcel Behr of McGill University. Scientists used the adjuvant to discover mechanisms that protect us from pathogens, including a new branch of the immune system. Freund’s innovation also allowed researchers to create animal models of multiple sclerosis (MS) and arthritis that were vital for deciphering what goes wrong in those illnesses and for developing and testing treatments. Even today, “it’s the ‘gold standard’ adjuvant” for work on those diseases, says immunologist Jay Reddy of the University of Nebraska-Lincoln. Read more about these immune-system boosters and Freund.👇
-
Recapping a successful AMR Symposium on June 8, 2026. MI4 was proud to support this impactful event featuring high-profile guest speakers and cutting-edge research. We were also delighted to present student awards for Best Poster Presentation: • 🥇 Shenmiao (Ivy) Li • 🥈 Anirudh Mantri Congratulations to the AMR Centre, led by Dr. Dao Nguyen, for hosting such an engaging symposium. Kudos to the AMR outreach team and MI4 volunteers who ensured everything ran seamlessly. #AMR #Symposium #ResearchExcellence #StudentSuccess #Collaboration #MI4Community
-
-
-
-
-
+2
-
-
MI4 reposted this
Congratulations to Assistant Professor Prativa Baral, PhD (Department of Global and Public Health, McGill Faculty of Medicine and Health Sciences), recipient of a CIHR STEPS Team Grant! 👏 Baral's team aims to create a new blueprint for public health emergencies: a pan-Canadian civilian emergency reserve. Working with co-lead Professor Joanne Liu, MDCM, FRCPC (McGill’s School of Population & Global Health) and partners Caroline Quach (National Director of Public Health in Quebec/Ministère de la santé et des services sociaux) and Conrad Sauvé (President and CEO of the Canadian Red Cross), the team will design models to strengthen Canada’s public health surge capacity. Learn more ➡️ https://lnkd.in/g37Y9TST
Strong public health systems are essential to preventing disease, promoting well-being, and reducing health inequities. Today, the Government of Canada and partners, Fonds de recherche du Québec, Heart & Stroke and Michael Smith Health Research BC announced an investment of over $10 million through the Strengthening Resilient and Equitable Public Health Systems (STEPS) initiative to support 14 research teams across the country. From strengthening emergency preparedness and responding to the opioid crisis to improving youth mental health services and advancing Indigenous-led approaches to health, these projects will generate evidence-informed solutions to build more resilient and equitable public health systems. Learn more: https://lnkd.in/enFRp4z9
-
-
“Those questions quickly became bigger than any one field.” In his own words, Dr. Irah King reflects on how microbiome research evolved from a focused scientific question into a deeply collaborative, interdisciplinary effort. From rethinking how we study microbes to building a research ecosystem at McGill, his perspective highlights what happens when disciplines—and people—come together. ➡️ Swipe through for key insights from the interview. Full article 👉 https://lnkd.in/e_3Drdfg #Microbiome #Leadership #ResearchInnovation #Collaboration #MI4 #MI4Community #McGill #MUHC
-
-
Congratulations to the MI4 Innovation Prize winners at this year’s McGill Clinical Innovation Competition! 🎉 AnemoSwab, developed by Yonatan Morocz and David Juncker, is redefining how we diagnose respiratory infections using exhaled breath to capture pathogen-containing aerosols, eliminating the need for invasive nasal swabs. This innovative approach has the potential to make testing faster, more comfortable, and more scalable – key steps toward improving early detection and reducing the spread of infectious diseases. Discover all winners of the 2026 CLIC Awards 👉 https://lnkd.in/eEn4g--T #MI4 #CLICAwards #MI4Prize #HealthcareInnovation #InfectiousDiseases #McGill #MedTech
-
-
From curiosity to collaboration → innovation. Microbiome research is transforming how we understand human health—from immunity and chronic pain to cancer and early-life development. In our latest feature, Dr. Irah King, Director of the McGill Centre for Microbiome Research, shares how advances in DNA sequencing sparked a new scientific frontier, and how collaboration turned that momentum into a thriving research hub at McGill. Discover how shared platforms, interdisciplinary partnerships, and long-term vision are driving impactful discoveries. Read the full interview 👉 https://lnkd.in/e_3Drdfg #Microbiome #ResearchImpact #Collaboration #Innovation #McGill #MUHC #HealthResearch #MI4Community #MI4HighlightsSeries
-
-
Carbapenem‑resistant infections are a growing global and local threat, limiting treatment options and increasing mortality in hospital settings. Yves Longtin and Dao Nguyen are leading a first‑of‑its‑kind Canadian study to track how these dangerous bacteria emerge and spread among patients. With seed support from MI4 and the Pathy Family Foundation, this project will generate critical insights to inform more effective infection control strategies, helping protect patients and strengthen hospital preparedness. 👉 https://lnkd.in/e_3Drdfg McGill University #mcgillu RI-MUHC | Research Institute of the MUHC | #rimuhc Fondation du Centre universitaire de santé McGill / McGill University Health Centre Foundation #MUHCF
-
-
Epstein–Barr virus (EBV) infection is increasingly linked to autoimmune diseases such as multiple sclerosis and certain kidney disorders—yet the mechanisms remain unclear. Simon Thebault and Ciriaco A. Piccirillo are investigating whether EBV acts as a common early trigger that programs immune cells toward autoimmune pathways across different organs. With seed support from MI4 and the Pathy Family Foundation, this project aims to uncover shared disease mechanisms—paving the way for more targeted, cross‑disease approaches to prevention and treatment. 👉 https://lnkd.in/e_3Drdfg McGill University #mcgillu RI-MUHC | Research Institute of the MUHC | #rimuhc Fondation du Centre universitaire de santé McGill / McGill University Health Centre Foundation #MUHCF
-
-
Congenital Chagas disease remains a critical gap in global health—treatments are often delayed during pregnancy due to limited safety data. Melisa Gualdrón‑López and Daniel Dufort are addressing this challenge by developing a pregnancy‑relevant testing pipeline using human placental models to evaluate safer therapies. With seed support from MI4 and the Pathy Family Foundation, this work has the potential to accelerate the development of safe treatments and protect newborns from infection, advancing care where it is urgently needed. 👉 https://lnkd.in/e_3Drdfg McGill University #mcgillu RI-MUHC | Research Institute of the MUHC | #rimuhc Fondation du Centre universitaire de santé McGill / McGill University Health Centre Foundation #MUHCF
-